Showing results (51-60 of 78) with videos related to

Sort By:
Pageof 8
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2007
Eotaxin-2 and colorectal cancer: a potential target for immune therapyEleanor J Cheadle, Kallingal Riyad, Daren Subar, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 14, 2014
Differential role of Th1 and Th2 cytokines in autotoxicity driven by CD19-specific second-generation chimeric antigen receptor T cells in a mouse modelEleanor J Cheadle, Victoria Sheard, Dominic G Rothwell, et al.
Human Gene Therapy|June 10, 2010
Functional expression of secreted proteins from a bicistronic retroviral cassette based on foot-and-mouth disease virus 2A can be position dependentDominic G Rothwell, Rachel Crossley, John S Bridgeman, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 26, 2010
Gene delivery of a mutant TGFβ3 reduces markers of scar tissue formation after cutaneous woundingSimon N Waddington, Rachel Crossley, Vicky Sheard, et al.
Cancer Immunology, Immunotherapy : CII|December 7, 2007
Vaccination of colorectal cancer patients with TroVax given alongside chemotherapy (5-fluorouracil, leukovorin and irinotecan) is safe and induces potent immune responsesRichard Harrop, Noel Drury, William Shingler, et al.
Cancer Immunology, Immunotherapy : CII|February 18, 2009
Immune evasion mechanisms in colorectal cancer liver metastasis patients vaccinated with TroVax (MVA-5T4)Eyad Elkord, Adam Dangoor, Deborah J Burt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2006
Vaccination of colorectal cancer patients with modified vaccinia Ankara delivering the tumor antigen 5T4 (TroVax) induces immune responses which correlate with disease control: a phase I/II trialRichard Harrop, Noel Connolly, Irina Redchenko, et al.
Cancer Immunology, Immunotherapy : CII|March 10, 2011
MVA-5T4-induced immune responses are an early marker of efficacy in renal cancer patientsRichard Harrop, William H Shingler, Mike McDonald, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 4, 2008
An MVA-based vaccine targeting the oncofetal antigen 5T4 in patients undergoing surgical resection of colorectal cancer liver metastasesEyad Elkord, Adam Dangoor, Noel L Drury, et al.
Cancer Immunology, Immunotherapy : CII|September 28, 2007
Adoptive transfer of T(reg) depleted autologous T cells in advanced renal cell carcinomaFiona C Thistlethwaite, Eyad Elkord, Richard W Griffiths, et al.
Pageof 8